Position in ANVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$5
-$117 QoQ
Shares Held
3
-94.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 61 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. ANVS ranks #373 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in ANVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5 | 3 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $122 | 55 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3 | 1 | Shares | Defined | 2026-02-13 | |
| 2023-12-31 | $209,383 | 11,197 | Shares | Defined | 2024-02-09 | |
| 2022-12-31 | $80 | 6 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $82 | 6 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $56 | 5 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,001 | 75 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $87 | 5 | Shares | Defined | 2022-02-10 | |
| 2021-03-31 | $8,453 | 303 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||